[go: up one dir, main page]

PL438097A1 - Method of preparing an oral film containing cannabidiol - Google Patents

Method of preparing an oral film containing cannabidiol

Info

Publication number
PL438097A1
PL438097A1 PL438097A PL43809721A PL438097A1 PL 438097 A1 PL438097 A1 PL 438097A1 PL 438097 A PL438097 A PL 438097A PL 43809721 A PL43809721 A PL 43809721A PL 438097 A1 PL438097 A1 PL 438097A1
Authority
PL
Poland
Prior art keywords
cannabidiol
solution
preparing
film containing
oral film
Prior art date
Application number
PL438097A
Other languages
Polish (pl)
Other versions
PL245075B1 (en
Inventor
Marcin BANACH
Olga DŁUGOSZ
Original Assignee
Dukebox Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dukebox Spółka Z Ograniczoną Odpowiedzialnością filed Critical Dukebox Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL438097A priority Critical patent/PL245075B1/en
Publication of PL438097A1 publication Critical patent/PL438097A1/en
Publication of PL245075B1 publication Critical patent/PL245075B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób otrzymywania doustnego filmu zawierającego kannabidiol o nanometrycznym rozmiarze cząstki, charakteryzujący się tym, że przygotowuje się roztwór wodny żelatyny albo gumy guar o stężeniu od 10 do 15% oraz roztwór izolatu kannabidiolu w propanodiolu albo w glikolu polietylenowym w stosunku masowym izolatu kannabidiolu do propanodiolu albo glikolu polietylenowego 1:1, po czym do roztworu żelatyny albo gumy guar dodaje się roztwór izolatu kannabidiolu przy stosunku masowym od 1:1 do 1,5:1, a następnie całość poddaje się działaniu ultradźwięków przez 5 do 15 min celem zdyspergowania, po czym gotową mieszaninę przenosi się do formy i pozostawia do zestalenia w temperaturze niższej albo równej 5°C.The subject of the application is a method for obtaining an oral film containing cannabidiol with a nanometric particle size, characterized by preparing an aqueous solution of gelatin or guar gum with a concentration of 10 to 15% and a solution of cannabidiol isolate in propanediol or polyethylene glycol in a mass ratio of cannabidiol isolate to propanediol or polyethylene glycol 1:1, then a solution of cannabidiol isolate is added to the gelatin or guar gum solution with a mass ratio of 1:1 to 1.5:1, and then the whole is subjected to ultrasound for 5 to 15 minutes to disperse, after which the finished mixture is transferred to a mold and allowed to solidify at a temperature of less than or equal to 5°C.

PL438097A 2021-06-08 2021-06-08 Method of obtaining an oral film containing cannabidiol PL245075B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL438097A PL245075B1 (en) 2021-06-08 2021-06-08 Method of obtaining an oral film containing cannabidiol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438097A PL245075B1 (en) 2021-06-08 2021-06-08 Method of obtaining an oral film containing cannabidiol

Publications (2)

Publication Number Publication Date
PL438097A1 true PL438097A1 (en) 2022-12-12
PL245075B1 PL245075B1 (en) 2024-05-06

Family

ID=84441524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438097A PL245075B1 (en) 2021-06-08 2021-06-08 Method of obtaining an oral film containing cannabidiol

Country Status (1)

Country Link
PL (1) PL245075B1 (en)

Also Published As

Publication number Publication date
PL245075B1 (en) 2024-05-06

Similar Documents

Publication Publication Date Title
CL2019001447A1 (en) Preparation of solid cyclodextrin complexes for the supply of ophthalmic active pharmaceutical ingredients.
TW398980B (en) Mixed-type hair treating composition while using
AR042340A1 (en) CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE TO A GREAT ENVIRONMENT
BRPI0409342A (en) heat-resistant homogeneous gel film, soft capsules, processes for making gel films and for making soft capsules containing gel films, and solid form
ATE434439T1 (en) METHOD FOR PRODUCING PREPARATIONS CONTAINING A STEROID HORMONE AND A STABILIZING AGENT IN NON-CRYSTALLINE FORM
JP3672008B2 (en) Hard capsule and method for producing the same
DE60319375D1 (en) Double-coated lactic acid bacteria powder with protein and polysaccharide and the process for their preparation and their dosage form
PL438097A1 (en) Method of preparing an oral film containing cannabidiol
DE60336602D1 (en) Process for the preparation of formulations for metered dose inhalers
CN101816622A (en) Bubble-formulation hair dye and preparation method thereof
RU2009128065A (en) THIN CONDOM
CN113018275B (en) Povidone empty capsule and production process thereof
JP2005137935A (en) Hard capsule and method for producing the same
CN106732215A (en) A kind of enhancing colloidal sol for moistening fragrant pearl for cigarette and preparation method thereof
CN103932897B (en) A kind of compositions for face moisture-keeping and preparation method thereof
CN119587466A (en) Amorolfine hydrochloride liniment and production process
CN103877587B (en) Medicinal enteric hard-shell capsule of a kind of vegetable polysaccharides and preparation method thereof
CH621259A5 (en)
CN108697605B (en) Photosensitive hair dye
CN106491538B (en) carbasalate calcium soluble powder and preparation method thereof
CN106038323A (en) Nanoscale fine alginate impression material
CN101003663A (en) Cast agent for blood vessel of no-solvent type epoxy resin
CN113956594B (en) A kind of water-based boron-free ultra-light clay formula and preparation method thereof
TW201521781A (en) Seaweed polysaccharides mask and manufacturing method thereof
CN112402603B (en) Thermosensitive adjuvant for aerosol immunization and preparation method thereof